CoronaVirus Research Opportunities: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{COVID-19 | {{COVID-19 | ||
| title = CoronaVirus Research Funding Opportunities | | title = CoronaVirus Research Funding Opportunities | ||
| team = Buildings | | team = Buildings | ||
| leader = Limor Schafman | | leader = Limor Schafman | ||
| image = COVIDResearchOpportunities.jpg | |||
| image = | |||
| imagecaption = Smart Building Supercluster | | imagecaption = Smart Building Supercluster | ||
| municipalities = | | municipalities = |
Revision as of 16:19, May 16, 2022
CoronaVirus Research Opportunities | |
---|---|
Smart Building Supercluster | |
Team Organizations | Buildings |
Team Leaders | Limor Schafman |
City, State | |
Contributors | |
Website | |
Document |
Description
CoronaVirus Research Opportunities List
BARDA
Open Now!
- Deadline October 31, 2020
- Weblink
- COVID-19 Medical Countermeasures Portal - Diagnostics, Vaccines, Therapeutics, Respiratory Protective Devices, Ventilators, Manufacturing Technologies
- BARDA BAA (Up to $8M, TRL 4+) & EZ (Up to $749K, earlier TRL) - Assays and Diagnostics, Screening, Vaccines, Manufacturing Tech
DoD
- SOCOM
- Due March 31 (Any possible COVID-19 solutions)
- Weblink
- MTEC
- Due April 8 -- Development of Treatment for COVID-19
- Weblink
- USAMRDC NPI Submissions - No deadline; responses within 10 days for certain assays
- XTechSearch
- Due March 31
- Weblink
- Medical Technologies
- Medical CBRN Defense Consortium: Open Now!; Closes May 31, 2020
- Weblink
- Diagnostics, Surveillance, POC, Therapeutics, Prophylactics, Clinical Trials
NSF SBIR for COVID-19
The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation's and world's ability to respond to the COVID-19 crisis. Areas of research that might be considered include, but are not limited to: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. Interested proposers are invited to submit to the NSF Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I Program. Project Pitch's responded to in 5 days, and applications may be funded in as little as 6 weeks from proposal submission. Phase I projects may have a bit more maturity than the normal NSF phase I projects. For more info, visit this weblink
- Open Now!
- [navy-sbir-sttr@navy.mil Weblink]
- Email 250 Word Abstract with Subject: "COVID-19 Pivot"
NIH
- Due March 31
- Weblink
- New Urgent Award Mechanism for COVID-19 R&D
FDA
- Weblink
- Regulatory Relief for Testing, Guidance for Clinical Trials & Development of Treatments
NSF
- Weblink
- Non-medical, non-clinical-care research on modeling and understanding the spread of COVID-19, inform/educate on science of virus transmission and prevention
VA
- Weblink
- "Fourth Mission" of emergency response
OSTP
- Weblink
- COVID-19 Open Research Dataset (CORD-19)